SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-289570
Filing Date
2018-10-01
Accepted
2018-10-01 16:28:36
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d624781ds3.htm S-3 322802
2 EX-4.4 d624781dex44.htm EX-4.4 270252
3 EX-4.5 d624781dex45.htm EX-4.5 279593
4 EX-5.1 d624781dex51.htm EX-5.1 14384
5 EX-23.1 d624781dex231.htm EX-23.1 1734
6 GRAPHIC g624781g02l24.jpg GRAPHIC 77177
7 GRAPHIC g624781g17p16.jpg GRAPHIC 73060
8 GRAPHIC g624781page126.jpg GRAPHIC 2979
  Complete submission text file 0001193125-18-289570.txt   1101329
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227638 | Film No.: 181097841
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1